Genet 41 , 234239 (2009)
this off-label use is not backed by the same level of controlled human trial evidence as the lipodystrophy indication Known risks and side effects: Injection site reactions, including erythema, pruritus, pain, and bruising at the injection site Arthralgia (joint pain) and peripheral edema (fluid retention), recognized class effects of GH-axis stimulation Increases in blood glucose and reduced insulin sensitivity, with clinical trials showing a higher rate of elevated HbA1c and new-onset hyperglycemia versus placebo Formation of anti-tesamorelin antibodies, reported in a substantial proportion of treated patients, with unclear long-term clinical significance Contraindicated in people with active malignancy, pituitary or hypothalamic disruption, or pregnancy, per FDA labeling Evidence snapshot: The strongest evidence is a set of Phase 3 human randomized controlled trials that supported FDA approval of tesamorelin for reducing visceral abdominal fat in HIV-associated lipodystrophy (approved 2010), plus a separate placebo-controlled human RCT (Baker et al., 2012, Archives of Neurology) showing improved executive function in older adults
The pentadecapeptide BPC 157 was also shown to counteract peritonitis and adhesion formation and to have a beneficial effect in diverse intestinal lesion models[30,36-40]
A thorough cost study shows : Full price for each batch of SLU-PP-332: 12% more money to invest at first Better handling of 5-amino-1MQ: 18% faster response times SLU-PP-332 cutting down on waste: 25% less stuff getting lost 5-amino-1MQ energy consumption: 15% lower heating requirements SLU-PP-332 gives you a better return on investment (ROI) if you want to lower your long-term costs by reducing waste and increasing store space
Frequency of Injections The frequency of B12 injections plays a significant role in determining how long B12 stays in the body
